NCT02287896View on ClinicalTrials.gov

Pharmacokinetics and Safety of Roledumab in RhD-negative Pregnant Women Carrying an RhD-positive Foetus

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 13, 2017

Study Completion Date

September 13, 2017

Conditions

Rh Disease

Interventions

DRUG

ROLEDUMAB

See Arm description

Trial Locations (8)

31059

Paule de Viguier Hospital, Toulouse

44093

University Hospital Center, Nantes

51092

Maison Blanche Hospital, Reims

59037

Jeanne de Flandre Hospital, Lille

69317

Croix-Rousse Maternity, Lyon

75012

Armand-Trousseau Hospital, Paris

75014

Port-Royal Maternity, Paris

78303

Poissy-Saint-Germain-en-Laye Hospital, Poissy

All Listed Sponsors

lead

Laboratoire français de Fractionnement et de Biotechnologies

INDUSTRY

NCT02287896 - Pharmacokinetics and Safety of Roledumab in RhD-negative Pregnant Women Carrying an RhD-positive Foetus | Biotech Hunter | Biotech Hunter